JN
Jay Nalinbhai Hirpara
About Jay Nalinbhai Hirpara
Data last updated:
Jay Nalinbhai Hirpara has 5 years in corporate governance. Holds Director role. Currently with 1 company, including Rextone Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Rextone Pharmaceuticals Private Limited at ₹0.04 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Rextone Pharmaceuticals Private Limited U74999GJ2021PTC125744 | Director | 21 Sep 2021 | 2021 | ₹0.04 Cr (FY 2025) | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Jay Nalinbhai Hirpara
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Jay Nalinbhai Hirpara
Jay Nalinbhai Hirpara has 5 years in corporate governance. Holds Director role. Currently with 1 company, including Rextone Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Rextone Pharmaceuticals Private Limited at ₹0.04 Cr (FY 2025).
Jay Nalinbhai Hirpara is associated with 1 company as Director, including Rextone Pharmaceuticals Private Limited (₹0.04 Cr).
Jay Nalinbhai Hirpara has expertise in General Business.
Jay Nalinbhai Hirpara has 5 years in corporate governance.
By reported revenue, the largest current company of Jay Nalinbhai Hirpara is Rextone Pharmaceuticals Private Limited, with revenue of ₹0.04 Cr (FY 2025).
Jay Nalinbhai Hirpara currently holds positions at 1 company: Rextone Pharmaceuticals Private Limited (₹0.04 Cr).